Discussion Posts

Thread Subject Replies Last Post Community
April 29 noon to 1pm ET Open Discussion FDA Draft Guidance: General Considerations for the Use of New Approach Methodologies in Drug Development
   
0 15 hours ago by Allison Radwick Chemistry, Manufacturing and Controls (CMC) Community
April 29 noon to 1pm ET Open Discussion FDA Draft Guidance: General Considerations for the Use of New Approach Methodologies in Drug Development
   
0 15 hours ago by Allison Radwick Translational and Clinical Science Community
April 29 noon to 1pm ET Open Discussion FDA Draft Guidance: General Considerations for the Use of New Approach Methodologies in Drug Development
   
0 15 hours ago by Allison Radwick Pharmaceutical Quality Community
Key Dates & Updates
   
1 2 days ago by Erica Schlesinger Global Health Community
April 29 noon to 1pm ET Open Discussion FDA Draft Guidance: General Considerations for the Use of New Approach Methodologies in Drug Development
   
0 2 days ago by Allison Radwick Regulatory Science Community
FDA publishes on NAMs in JAMA
   
0 3 days ago by Mark Arnold Translational and Clinical Science Community
Welcome from your Regulatory Science Community Leaders - and a Look at What's Ahead
   
4 3 days ago by HaiAn Zheng
Original post by Allison Radwick 		Regulatory Science Community
Establishing Impurity Specifications for Antibiotics - Comments by 6/22/2026
   
0 3 days ago by Kim Huynh-Ba Pharmaceutical Quality Community
PEPFAR and Global Fund to help expand access to Lenacapavir (HIV Prevention)
   
0 4 days ago by Sravan Kumar Patel Global Health Community
[AAPS] Translational and Clinical Science Community meeting
   
2 6 days ago by Steven Louie
Original post by Hiroshi Sugimoto 		Translational and Clinical Science Community
Showing 1 to 10 of 99 threads (99 total posts)